This article was originally published in Scrip
Alan Kay, who conceived the object-orientated programming approach that underpins Apple’s computer systems once famously said “The best way to predict the future is to invent it.” Kay’s own innovative genius was to recognise that in virtually all activities the modern species of Homo was still fundamentally habilis, the tool-user. While words and pseudowords such as computer code serve for recording and intellectual discourse, Homo sapiens macuserensis is still rather more comfortable with things and actions.
You may also be interested in...
Cambridge, UK-based Healx has concluded a $56m series B round, led by Atomico, to put up to 50 potential rare disease treatments into the clinic within two years using its AI/ML platform.
Tapping into the ability of arenaviruses to deliver prolonged local immune activation, rapid regression of localized and metastatic cancers, and long-term disease control, Essen, Germany-based start-up Abalos Therapeutics has raised €12m to advance its lead candidates towards clinical testing.
Celgene agrees to pay $75m upfront for options to three Immatics TCR-T targets for solid tumors. Deal could be worth up to $1.59bn to the German biotech, which also retains option to co-develop and co-fund certain licensed products.